The CASL Clinical Hepatology Fellowship aims to support those with a primary interest in liver disease to provide advanced training in the clinical management and research of liver diseases.
Awards and Duration:
Each application for funding will be considered as a new application.
Applicants who require assistance to complete an application should contact the CASL Office event via email. It is the applicant’s responsibility to ensure that all required documents reach the Association by the deadlines. We will not contact applicants to pursue missing information.
Applicants with a primary interest in liver disease are eligible to apply. Applicants for fellowships must be members of the Canadian Association for the Study of the Liver (CASL). Canadian citizens landed immigrants and permanent residents will receive first consideration. The Canadian Association for the Study of the Liver (CASL) reserves the right not to review applications that do not respect the above requirements.
CASL Clinical Fellowship
Clinical Fellowships are intended for candidates pursuing additional training in advanced clinical hepatology. Applicants who have completed Internal Medicine or Gastroenterology training and intend to devote their future clinical practice to the management of adult or pediatric patients with liver diseases in Canada are prioritized. The fellowship placement will begin in the year following the application.
The purpose of these awards is to allow young clinicians to receive additional training in advanced clinical hepatology, and, thereby ultimately, to increase the number of practicing hepatologists in Canada.
Deadline: Upload and submit your application along with all required documents by September 30, 2025
Application Process
Required Documents
Criteria for Scoring
Members of the CASL Education Committee will review all applications based on the following criteria:
General Guidelines
The fellow’s host institution accounting office must submit a statement of expenditures related to the fellowship within 60 days of the end of the fellowship.
An interim progress report must be submitted by fellowship holders 6 months after the start date of the fellowship to the Canadian Association for the Study of the Liver (CASL).
A brief final report must be submitted by fellowship holders within 60 days of the end of the fellowship term. This progress report should note objectives met and highlight successes and challenges or barriers encountered in the accomplishment of the goals set out in the fellowship application.
A fellowship recipient who has not submitted a satisfactory progress report and/or final report to the Canadian Association for the Study of the Liver will be barred from submitting a grant or fellowship proposal to CASL in future competitions. This bar may only be lifted upon receipt of a satisfactory progress and/or final report(s).
Terms of Award
Clinical Fellowships are for a period of one year.
The Clinical Fellowship is intended to provide income to the recipient throughout their hepatology fellowship. The award is to be used to cover living expenses while completing the fellowship.
The applicant may request an award of up to $70,000. The application must include an outline of how the funds will be used, including any employer obligations as per CRA regulations.
The applicant must provide evidence of the likelihood of practicing in Canada following their fellowship, as the intent of this funding is to further the treatment of liver disease within Canada. The application for fellowship should explicitly address this issue.
The supervisor for the applicant is required to review and sign off on the terms of the award.
The Fellowship will normally commence on July 1,2026. The Association will make payments to the fellow’s institution, to then be paid out as per the terms of the fellowship. Fellowships starting on dates other than July 1 will be accepted but start dates should be expressly noted in the fellowship application to allow for expedient payment.
If at any point in time, the recipient needs to delay the fellowship, a request must be made in writing to the Canadian Association for the Study of the Liver. NOTE: additional funding will not be provided for the additional time taken.
Any changes or questions regarding the payment instructions above must be made in writing, within 30 days of accepting the fellowship.
Access to any Publications
🩺 1. Membership and Canadian Clinical Focus
Applicants must be CASL members and typically are Canadian citizens or permanent residents for priority consideration
Fellowship applicants should already have completed training in Internal Medicine, Pediatrics, or Gastroenterology and intend to specialize in liver disease clinical care or research PSC Partners Canada+11hepatology.ca+11hepatology.ca+11hepatology.ca.
📚 2. Clinical Hepatology Fellowship
The CASL Clinical Hepatology Fellowship supports advanced training in clinical and research aspects of liver disease
1‑year duration, begins the year after application, with deadlines typically September 30 for the following year’s cohort hepatology.ca+2hepatology.ca+2hepatology.ca+2hepatology.ca+1hepatology.ca+1.
Key predictors: strong clinical experience or training, alignment with hepatology career goals, and institutional support from Canadian institutions.
🔬 3. Basic & Clinical Research Grants
CLF and CASL jointly fund pilot and operating research grants, including co-funded awards of ~CAD 125,000 over two years in partnership with Cancer Research Society hepatology.ca.
These support hypothesis-driven projects across pediatric and adult liver disease, including hepatology, transplantation, and rare liver conditions hepatology.ca+7hepatology.ca+7hepatology.ca+7.
🧪 4. Pilot & Studentship Programs
CLF also offers summer studentships, graduate studentships, and designated research grants (e.g. Hepatitis B, pediatric hepatobiliary topics) focused on generating preliminary data and fostering training hepatology.ca+2liver.ca+2hepatology.ca+2.
Focused on Canadian Liver Disease Priorities
Projects must clearly address liver-related conditions and be executed within a Canadian context.
Strong mentorship and institutional support
Early-career applicants (e.g. postdocs or trainees) score higher when supported by experienced CASL members from recognized Canadian hepatology centers.
Preliminary data & Realistic Scope
Proposals should include pilot data or a well-rationalized plan, with milestones and outcomes achievable within 1–2 years.
Translational & Career-Building Potential
Preference for projects that generate data toward future CIHR, NIH, or foundation grant applications.
Academic Productivity
A history of publications, conference presentations (especially CASL annual meeting), or demonstrated research involvement enhances competitiveness hepatology.caPMC.
| Program/Funding | Audience | Indicators of Prior Success |
|---|---|---|
| CASL Clinical Fellowship | Trainees in liver medicine | CASL membership; clear hepatology focus; Canadian training plan |
| CLF / CASL Research Grants | Postdocs, junior faculty | Canadian institution affiliation; preliminary data; peer-reviewed research plan |
| Studentships & Pilot Projects | Graduate or medical students | Clear research focus; mentorship; feasibility; relevant topic area |
🎯 Final Tips for Application Success
Join CASL and demonstrate engagement (e.g., abstracts) with CASL meetings.
Choose research questions aligned with CASL/CLF mandates (e.g. PSC, hepatitis, NASH, transplantation).
Provide proof-of-concept data, realistic milestones, and a pathway to future funding.
Ensure your application is backed by a Canadian hepatology sponsor at an established center.
Applicants with a primary interest in liver disease are eligible to apply. Applicants for fellowships must be members of the Canadian Association for the Study of the Liver (CASL). Canadian citizens landed immigrants and permanent residents will receive first consideration. The Canadian Association for the Study of the Liver (CASL) reserves the right not to review applications that do not respect the above requirements.
Eligible Countries:
Sponsor Institute/Organizations: Canadian Association for the Study of the Liver
Sponsor Type: Corporate/Non-Profit
Address: PO BOX 19020 Vancouver RPO 4th Ave, BC, V6K 4R8
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Sep 30, 2025
Sep 30, 2025
$70,000
Affiliation: Canadian Association for the Study of the Liver
Address: PO BOX 19020 Vancouver RPO 4th Ave, BC, V6K 4R8
Website URL: https://hepatology.ca/education-events/clinical-fellowships/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.